The role of oxygen free radicals in cisplatin-induced acute renal failure in rats

Journal of Laboratory and Clinical Medicine

Volumn 131, Issue 6, 1998, Pages 518-526

  Matsushima, Hideki ^a   Yonemura, Katsuhiko ^a   Ohishi, Kazuhisa ^a   Hishida, Akira ^a  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0032102143     PISSN: 00222143     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-2143(98)90060-9     Document Type: Article

References (40)

1. Winston JA, Safirstein R. Reduced renal blood flow in early cisplatin-induced acute renal failure in the rat. Am J Physiol 1985;249:F490-6.
2. Chopra S, Kaufman JS, Jones TW, Hong WK, Gehr MK, Hamburger RJ, et al. Cis-diammine-dichloroplatinum-induced acute renal failure in the rat. Kidney Int 1982;21:54-64.
3. Dobyan DC, Levi J, Jacobs C, Kosek J, Weiner MW. Mechanism of cis-platinum nephrotoxicity. II. Morphologic observations. J Pharmacol Exp Ther 1980;213:551-6.
4. Dobyan DC, Bull JM, Strebel FR, Sunderland BA, Bulger RE. Protective effects of O-(beta- hydroxyethyl)-rutoside on cis-platinum-induced acute renal failure in rat. Lab Invest 1986;55:557-63.
5. Gordon JA, Gattone VH II. Mitochondrial alterations in cisplatin-induced acute renal failure. Am J Physiol 1986;250:F991-F8.
6. Jones TW, Chopra S, Kaufman JS, Flamenbaum W, Trump B. Cis-diamminedichloroplatinum(II)-induced acute renal failure in the rat. Lab Invest 1985;52:363-74.
7. Laurent G, Yernaux V, Nonclercq D, Toubeau G, Maldague P, Tulkens PM, et al. Tissue injury and proliferative response induced in rat kidney by cis-diammine dichloroplatinum (II). Virchows Arch B Cell Pathol 1988;55:129-45.
8. Weiner MW, Jacobs C. Mechanisms of cisplatin nephrotoxicity. Federation Proc 1983;42:2974-8.
9. Safirstein R, Winston J, Goldstein M, Moel D, Dikman S, Guttenplan J. Cisplatin nephrotoxicity. Am J Kidney Dis 1986;8:356-67.
10. Gamelin LM, Zager RA. Evidence against oxidant injury as a critical mediator of postischemic acute renal failure. Am J Physiol 1988;255:F450-60.
11. Paller MS, Hoidal JR, Ferris TF. Oxygen free radicals in ischemic acute renal failure in the rat. J Clin Invest 1984;74:1156-64.
12. Zager RA. Hypoperfusion-induced acute renal failure in the rat: An evaluation of oxidant tissue injury. Circ Res 1988;62:430-5.
13. Zager RA, Fuerstenberg SM, Baehr PH, Myerson D. Torok-Storb B. An evaluation of antioxidant effects on recovery from postischemic acute renal failure. J Am Soc Nephrol 1994;4:1588-97.
14. Kato A, Hishida A, Nakajima T. Effects of oxygen free radical scavengers on uranium-induced acute renal failure in rats. Free Radic Biol Med 1994;16:855-9.
15. Nakajima T, Hishida A, Kato A. Mechanisms for protective effects of free radical scavengers on gentamicin-mediated nephropathy in rats. Am J Physiol 1994;266:F425-31.
16. Palier MS. Free radical scavenger in mercuric chloride-induced acute renal failure in the rat. J Lab Clin Med 1985;105:459-63.
17. Shah VS, Walker PD. Evidence suggesting a role for hydroxyl radical in glycerol-induced acute renal failure. Am J Physiol 1988;255:F438-43.
18. Masuda H, Tanaka T, Takahama U. Cisplatin generates superoxide anion by interaction with DNA in a cell-free system. Biochem Biophys Res Commun 1994;203:1175-80.
19. Kruidering M, van de Water B, de Heer E, Mulder GJ, Nagelkerke JF. Cisplatin-induced nephrotoxicity in porcine proximal tubular cells: Mitochondrial dysfunction by inhibition of complexes I to IV of the respiratory chain. J Pharmacol Exp Ther 1997;280:638-49.
20. Nakano S, Gemba M. Potentiation of cisplatin-induced lipid peroxidation in kidney cortical slices by glutathione depletion. Jpn J Pharmcol 1989:50:87-92.
21. Sugihara K, Nakano S, Koda M, Anaka K, Fukuishi N, Gemba M. Stimulatory effect of cisplatin on production of lipid peroxidation in renal tissues. Jpn J Pharmacol 1987;43:247-52.
22. Sugihara K, Nakano S, Gemba M. Effect of cisplatin on in vitro production of lipid peroxides in rat kidney cortex. Jpn J Pharmacol 1987;44:71-6.
23. Babu E, Gopalakrishnan VK, Sriganth INP, Gopalakrishnan R, Sakthisekaran D Cisplatin induced nephrotoxicity and the modulating effect of glutathione ester. Mol Cell Biochem 1995;144:7-11.
24. McGinness JE, Proctor PH, Demopoulos HB, Hokanson JA, Kirkpatrick DS. Amelioration of cis-platinum nephrotoxicity by orgotein (superoxide dismutase). Physiol Chem Physics 1978;10:267-77.
25. Ohishi K, Carmines PK. Superoxide dismutase restores the influence of nitric oxide on renal arterioles in diabetes mellitus. J Am Soc Nephrol 1995;5:1559-66.
26. Tanizawa H, Sazuka Y, Takino Y. Micro-determination of lipoperoxide in the mouse myocardium by thiobarbituric acid fluorophotometry. Chem Pharm Bull (Tokyo) 1981;29:2910-4.
27. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951;193:265-75.
28. Husain K, Morris C, Whitworth C, Trammel GL, Rybak LP, Somani SM. 4-Methylthiobenzoic acid protection against cisplatin nephrotoxicity: Antioxidant system. Fundam Appl Toxicol 1996;32:278-84.
29. Somani SM, Ravi R, Rybak LR Diethyldithiocarbamate protection against cisplatin nephrotoxicity: Antioxidant system. Drug Chem Toxicol 1995;18:151-70.
30. Wasil M, Halliwell B, Grootveld M, Moorhouse CP, Hutchison DCS, Baum H. The specificity of thiourea, dimethyl thiourea and dimethyl sulphoxide as scavengers of hydroxyl radicals: Their protection of α1-antiproteinase against inactivation by hydrochlorous acid. Biochem J 1987;243:867-870.
31. Smith CV, Anderson RE. Methods for determination of lipid peroxidation in biological samples. Free Radic Biol Med 1987;3:341-4.
32. Janero DR. Malondialdehyde and thiobarbituric acid-reactivity as diagnostic indices of lipid peroxidation and peroxidative tissue injury. Free Radic Biol Med 1990;9:515-40.
33. Ohtake T, Kimura M, Nishimura M, Hishida A. Roles of reactive oxygen species and antioxidant enzymes in murine daunomycin-induced nephropathy. J Lab Clin Med 1997;129:81-8.
34. Ignarro LJ, Buga GM, Wood KS, Byrns RE, Chaudhuri G. Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci U S A 1987;84:9265-9.
35. Tolins JP, Palmer RMJ, Moncada S, Rail L. Role of endothelium-derived relaxing factor in regulation of renal hemodynamic responses. Am J Physiol 1985;258:H655-62.
36. Gryglewski RJ, Palmer RMJ, Moncada S. Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor. Nature (London) 1986;320:454-6.
37. Rubanyi GM, Vanhoutte PM. Superoxide anions and hypoxia inactivate endothelium-derived relaxing factor. Am J Physiol 1986;250:H822-7.
38. Igarashi R, Hoshino J, Takenaga M, Kawai S, Morizawa Y, Yasuda A, et al. Lecithinization of superoxide dismutase potentiates its protective effect against Forssman antiserum-induced elevation in guinea pig airway resistance. J Pharmacol Exp Ther 1992;262:1214-9.
39. Bravo R, Frank R, Blundell PA, Macdonald-Bravo H. Cyclin/PCNA is the auxiliary protein of DNA polymerase-δ. Nature (London) 1987;326:515-7.
40. Garcia RL, Coltrera MD, Gown AM. Analysis of proliferative grade using anti-PCNA/cyclin monoclonal antibodies in fixed, embedded tissue. Am J Pathol 1989;134:733-9.